Clinical trials
Multiple Organ Failure trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 52 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chang Gung Memorial Hospital | 3 |
| University of Rostock | 2 |
| Air Force Military Medical University, China | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Centro Cardiologico Monzino | 1 |
| Chinese PLA General Hospital | 1 |
| Croatian Society for Organ Support | 1 |
| Efficacy Care R&D Ltd | 1 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Organ Failure | 52 |
| Sepsis | 20 |
| Shock, Septic | 9 |
| Respiratory Distress Syndrome | 6 |
| Acute Kidney Injury | 5 |
| Shock | 4 |
| Systemic Inflammatory Response Syndrome | 4 |
| Critical Illness | 3 |
| Pancreatitis | 3 |
| Respiratory Insufficiency | 3 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.